Log In
Print this Print this

Grazax (grass pollen Allergy Immunotherapy Tablet (AIT), Grastek) (MK-7243)

Also known as: Grass pollen allergen tablet

  Manage Alerts
Collapse Summary General Information
Company ALK-Abello A/S
DescriptionTablet-based sublingual allergen immunotherapy
Molecular Target Not applicable
Mechanism of ActionImmunotherapy
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationAllergy
Indication DetailsPrevent development of asthma in children with allergic rhinoconjunctivitis; Treat grass pollen allergy; Treat grass pollen-induced allergic rhinoconjunctivitis (hay fever); Treat mild to moderate hay fever; Treat moderate to severe hay fever; Treat Timothy grass pollen induced allergic rhinitis, with or without conjunctivitis
Regulatory Designation
PartnerAbbott Laboratories;
Merck & Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today